* Bausch Health Companies Inc BHC.TO is expected to show
a rise
in quarterly revenue when it reports results on February 22 for
the period ending December 31 2023
* The Laval Quebec-based company is expected to report a
4.8% increase in revenue to $2.299 billion from $2.19 billion a
year ago, according to the mean estimate from 5 analysts, based
on LSEG data. (Majority is on Total Revenue basis)
* LSEG's mean analyst estimate for Bausch Health Companies
Inc is
for earnings of $1.00 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Bausch
Health
Companies Inc is $8.75, below its last closing price
of C$11.48.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.92 0.90 1.02 Beat 13.9
Jun. 30 2023 0.76 0.76 0.82 Beat 7.6
Mar. 31 2023 0.73 0.72 0.52 Missed -27.6
Dec. 31 2022 0.92 0.91 1.03 Beat 13.7
Sep. 0.84 0.87 0.76 Missed -12.6
30 2022
Jun. 30 2022 0.89 0.89 0.56 Missed -37.3
Mar. 31 2022 1.00 1.03 0.73 Missed -28.9
Dec. 31 2021 1.12 1.11 1.28 Beat 15
This summary was machine generated February 20 at 13:57 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)